[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351848-105":59,"doc-detail-351848-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","supporting-breast-and-cervical-cancer-screening-follow-up-qualitative-health-plan-interviews","Supporting breast and cervical cancer screening follow-up: qualitative health plan interviews","","Breast and cervical cancer impose substantial health burdens, and follow-up after abnormal screening results is critical for outcomes. The National Committee for Quality Assurance (NCQA) sought to determine whether health plan electronic clinical data systems can support quality measures tracking follow-up for abnormal breast and cervical cancer screening test results. NCQA interviewed quality improvement leaders from ten health plans to identify feasibility, barriers, and opportunities for measure development using electronic data.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/supporting-breast-and-cervical-cancer-screening-follow-up-qualitative-health-plan-interviews/351848/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/supporting-breast-and-cervical-cancer-screening-follow-up-qualitative-health-plan-interviews/351848.png","ImageObject",300,407,{"name":92,"@type":93},"Jasmine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of the study?","Question",{"text":113,"@type":114},"To assess the feasibility of using health plan electronic clinical data systems to develop quality measures for follow-up after abnormal breast and cervical cancer screening results.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were participants selected and what was the study approach?",{"text":118,"@type":114},"NCQA interviewed quality improvement leaders from ten health plans recruited through purposive sampling to reflect diverse sizes, regions, and product lines.",{"name":120,"@type":111,"acceptedAnswer":121},"What barriers and opportunities were reported?",{"text":122,"@type":114},"Leaders identified barriers such as lack of standardized data integration, and opportunities including support for provider and health system data aggregation and other supportive resources.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351848,1790472758,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Lin etal. BMC Health Services Research (2026) 26:860 BMC Health Services Research  \n[https://doi.org/10.1186/s12913-026-14641-9](https://doi.org/10.1186/s12913-026-14641-9)  \nRESEARCH Open Access  \nSupporting breast and cervical cancer screening follow-up: qualitative health plan interviews  \nBrenna Lin 1*, Kathleen Gruschow1, Alana Burke 1, Xiaofei Zhou1, Thomas B. Richards2 and Sepheen C. Byron 1  \nAbstract  \nBackground Breast and cervical cancer represent a significant disease burden. Health care quality measures captured through electronic clinical data systems could be used to assess follow-up of abnormal breast and cervical cancer screening results. The National Committee for Quality Assurance (NCQA) wanted to explore the feasibility of using health plan electronic clinical data systems to develop quality measures for follow-up of abnormal breast and cervical cancer screening test results.  \nMethods NCQA interviewed quality improvement leaders from ten health plans, recruited through a purposivesample representing varying sizes, geographic regions, and commercial, Medicare, and Medicaid product lines. Results Health plan leaders identified several barriers, including a lack of standardized data integration as well as opportunities such as supporting provider and health system data aggregation and other support.  \nConclusions Findings indicate that improved data governance, particularly around data standardization and information technology infrastructure integration, would increase the feasibility of monitoring follow-up after abnormal breast and cervical cancer screening results.  \nKeywords Health care quality, Cancer screening, Cancer follow-up  \n*Correspondence: Brenna Lin[blin@ncqa.org](blin@ncqa.org)  \n1Quality Measurement and Research Group, National Committee for Quality Assurance, 1100 13th St NW 3rd floor, Washington, DC 20005, USA 2Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nLin et al. BMC Health Services Research (2026) 26:860 Page 2 of 8  \nText box 1. Contributions to the literature  \n• This paper summarizes perspectives from health plan representatives on barriers and opportunities for breast and cervical cancer screening follow-up.  \n• Health plan representatives highlighted some challenges in obtaining and structuring data needed for tracking follow-up.  \n• We suggest considerations for data governance to support improving quality of care for patients with abnormal breast and cervical cancer screening results.  \nBackground  \nBreast and cervical cancers represent a significant disease burden. In 2020, there were 4272 reported deaths related to cervical cancer and 42,273 deaths related to breast cancer in the United States [1, 2]. While there has been some success in disease management due to increased attention on screening programs, outcome improvement relies on proper follow-up of abnormal test results [3]. Currently, howeve","cbCailRcUn33uxh3","https://ap.wps.com/l/cbCailRcUn33uxh3","pdf",759571,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Contributions to the literature\n## Key contributions","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To assess the feasibility of using health plan electronic clinical data systems to develop quality measures for follow-up after abnormal breast and cervical cancer screening results.\"},{\"question\":\"How were participants selected and what was the study approach?\",\"answer\":\"NCQA interviewed quality improvement leaders from ten health plans recruited through purposive sampling to reflect diverse sizes, regions, and product lines.\"},{\"question\":\"What barriers and opportunities were reported?\",\"answer\":\"Leaders identified barriers such as lack of standardized data integration, and opportunities including support for provider and health system data aggregation and other supportive resources.\"}]","Supporting breast and cervical cancer screening follow-up: qualitative health plan interviews | PDF",1790096298,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/121753ef27e63f032d8de64cbf773ad0.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61d8cecc70c5ec55e374f7640303598d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/872129126fa47ba1ae2c5e96de7c3971.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e94755490af67043767972cc4111a3e4.webp",980,1306]